You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBIX Exercise Disclosure
Lippoldt Darin · SEC Form 4 · Filed Jun 30, 2026
Exercise
Calculated transaction value
$137.72K
Lippoldt Darin Chief Legal Officer
NBIX
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
NBIX daily price context
Close on/before transaction
$170
Jun 29, 2026
First close after public filing
$167.77
Jul 1, 2026
30-day return after filing
+10.57%
Through Jul 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,690 shares @ $81.49
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001504783-26-000015
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$2.52M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Sale | Jun 29, 2026 | $288.68K |
| Neurocrine Biosciences Inc NBIX Current | Exercise | Jun 29, 2026 | $137.72K |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 29, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 29, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 29, 2026 | $660.88K |
| Neurocrine Biosciences Inc NBIX | Sale | Jun 29, 2026 | $1.38M |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 26, 2026 | $16.3K |
| Neurocrine Biosciences Inc NBIX | Sale | Jun 26, 2026 | $33.91K |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 26, 2026 | $0 |